Literature DB >> 11988083

Elevation of hepatic sulphotransferase activities in mice with resistance to cystic fibrosis.

Josie L Falany1, Heather Greer, Timea Kovacs, Eric J Sorscher, Charles N Falany.   

Abstract

The severity of intestinal disease in the cystic fibrosis (CF) transmembrane conductance regulator (CFTR) (-/-) mice has been reported to co-segregate with gene loci which contain the genes for hydroxysteroid sulphotransferase (SULT). Because of the potential involvement of steroid hormones in CF, we investigated levels of steroid SULT activity in the livers of CFTR mice to determine whether the levels of SULT activity correlate with the occurrence or severity of CF. To elucidate the possible role of SULT activity in ameliorating the deleterious effects of CF in CFTR (-/-) mice, we determined the levels of phenol SULT (PST), hydroxysteroid SULT [dehydroepiandrosterone (DHEA)-ST] and oestrogen SULT (EST) activity in control CFTR (+/+), heterozygous CFTR (+/-) and homozygous CFTR (-/-) mice, which survive to adulthood. The level of PST activity was not significantly different between any of the groups of mice, regardless of sex or genotype. Although DHEA-ST activity was significantly higher in female mice than in male mice, there was no difference in DHEA-ST activity that could be correlated with genotype. In contrast with PST and DHEA-ST activities, we found that some male and all female adult CFTR (-/-) mice had elevated, dramatically different levels of EST from both CFTR (+/+) and CFTR (+/-) mice. Results from these SULT activity experiments were confirmed by Northern-blot analysis of mouse-liver RNA. Subsequent studies with preweanling mice revealed no differences in the levels of EST that could be correlated with genotype. Thus this study indicates that EST is elevated significantly in CFTR (-/-) mice which survive to adulthood and provides important biochemical information that EST levels may be protective in CF.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11988083      PMCID: PMC1222552          DOI: 10.1042/bj3640115

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

Review 1.  The gender gap in cystic fibrosis survival.

Authors:  P B Davis
Journal:  J Gend Specif Med       Date:  1999 Mar-Apr

2.  Association of variant alleles of mannose binding lectin with severity of pulmonary disease in cystic fibrosis: cohort study.

Authors:  M Gabolde; M Guilloud-Bataille; J Feingold; C Besmond
Journal:  BMJ       Date:  1999-10-30

3.  Estrogen inhibition of cystic fibrosis transmembrane conductance regulator-mediated chloride secretion.

Authors:  A K Singh; B D Schultz; J A Katzenellenbogen; E M Price; R J Bridges; N A Bradbury
Journal:  J Pharmacol Exp Ther       Date:  2000-10       Impact factor: 4.030

4.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

Review 5.  The genetics of diabetes susceptibility in mice.

Authors:  E H Leiter
Journal:  FASEB J       Date:  1989-09       Impact factor: 5.191

6.  Synergism of obesity genes with hepatic steroid sulfotransferases to mediate diabetes in mice.

Authors:  E H Leiter; H D Chapman; C N Falany
Journal:  Diabetes       Date:  1991-10       Impact factor: 9.461

7.  An animal model for cystic fibrosis made by gene targeting.

Authors:  J N Snouwaert; K K Brigman; A M Latour; N N Malouf; R C Boucher; O Smithies; B H Koller
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

8.  Purification and characterization of human liver phenol-sulfating phenol sulfotransferase.

Authors:  C N Falany; M E Vazquez; J A Heroux; J A Roth
Journal:  Arch Biochem Biophys       Date:  1990-05-01       Impact factor: 4.013

9.  Purification and characterization of human liver dehydroepiandrosterone sulphotransferase.

Authors:  C N Falany; M E Vazquez; J M Kalb
Journal:  Biochem J       Date:  1989-06-15       Impact factor: 3.857

10.  Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis.

Authors:  M Knowles; J Gatzy; R Boucher
Journal:  N Engl J Med       Date:  1981-12-17       Impact factor: 91.245

View more
  9 in total

1.  Regulation of hepatic sulfotransferase (SULT) 1E1 expression and effects on estrogenic activity in cystic fibrosis (CF).

Authors:  Charles N Falany; Dongning He; Li Li; Josie L Falany; Teresa W Wilborn; Thomas A Kocarek; Melissa Runge-Morris
Journal:  J Steroid Biochem Mol Biol       Date:  2009-03-03       Impact factor: 4.292

2.  Lack of substrate inhibition in a monomeric form of human cytosolic SULT2A1.

Authors:  Ian T Cook; Thomas S Leyh; Susan A Kadlubar; Charles N Falany
Journal:  Horm Mol Biol Clin Investig       Date:  2010-12

Review 3.  Regulation of the cytosolic sulfotransferases by nuclear receptors.

Authors:  Melissa Runge-Morris; Thomas A Kocarek; Charles N Falany
Journal:  Drug Metab Rev       Date:  2013-02       Impact factor: 4.518

Review 4.  Growth hormone-STAT5 regulation of growth, hepatocellular carcinoma, and liver metabolism.

Authors:  Myunggi Baik; Ji Hoon Yu; Lothar Hennighausen
Journal:  Ann N Y Acad Sci       Date:  2011-07       Impact factor: 5.691

5.  Repression of CFTR activity in human MMNK-1 cholangiocytes induces sulfotransferase 1E1 expression in co-cultured HepG2 hepatocytes.

Authors:  Dongning He; Teresa W Wilborn; Josie L Falany; Li Li; Charles N Falany
Journal:  Biochim Biophys Acta       Date:  2008-09-11

6.  HE3286, an oral synthetic steroid, treats lung inflammation in mice without immune suppression.

Authors:  Douglas Conrad; Angela Wang; Raymond Pieters; Ferdinando Nicoletti; Katia Mangano; Anna M van Heeckeren; Steven K White; James M Frincke; Christopher L Reading; Dwight Stickney; Dominick L Auci
Journal:  J Inflamm (Lond)       Date:  2010-10-30       Impact factor: 4.981

7.  Hyposulfatemia, growth retardation, reduced fertility, and seizures in mice lacking a functional NaSi-1 gene.

Authors:  Paul A Dawson; Laurent Beck; Daniel Markovich
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-24       Impact factor: 11.205

8.  Increased SULT1E1 activity in HepG2 hepatocytes decreases growth hormone stimulation of STAT5b phosphorylation.

Authors:  Li Li; Dongning He; Teresa W Wilborn; Josie L Falany; Charles N Falany
Journal:  Steroids       Date:  2008-09-11       Impact factor: 2.668

9.  A trans fatty acid substitute enhanced development of liver proliferative lesions induced in mice by feeding a choline-deficient, methionine-lowered, L-amino acid-defined, high-fat diet.

Authors:  Noriko Suzuki-Kemuriyama; Akari Abe; Kinuko Uno; Shuji Ogawa; Atsushi Watanabe; Ryuhei Sano; Megumi Yuki; Katsuhiro Miyajima; Dai Nakae
Journal:  Lipids Health Dis       Date:  2020-12-14       Impact factor: 3.876

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.